$LTGO
Latigo Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$22.55
▼-5.77%-$1.38
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLatigo Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LTGO down today? It is at $22.55 (-5.77%), and our scanner flagged it 45 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LTGO spikes, and full due diligence on LTGO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LTGO 45 times in the last 30 days. Create a free account to track $LTGO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LTGO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LTGO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Seidenberg Beth C Director | Acquired (grant/award) | +12.70M 19.1% of company | added 100% | 13.20M | n/a | Aug 10, 26 |
Tananbaum James B. Director | Bought (open market) | +140K 0.2% of company | added 7.5% | 2.01M | $2.5M at $18.00 | Aug 10, 26 |
Tananbaum James B. Director | Acquired (grant/award) | +9.04M 13.6% of company | added 100% | 9.18M | n/a | Aug 10, 26 |
Foresite Capital Management V, Llc Beneficial Owner (10%) | Bought (open market) | +140K 0.2% of company | added 7.5% | 2.01M | $2.5M at $18.00 | Aug 10, 26 |
Foresite Capital Management V, Llc Beneficial Owner (10%) | Acquired (grant/award) | +9.04M 13.6% of company | added 100% | 9.18M | n/a | Aug 10, 26 |
Westlake Biopartners Fund I, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +12.70M 19.1% of company | added 100% | 13.20M | n/a | Aug 10, 26 |
Sanofi Beneficial Owner (10%) | Acquired (grant/award) | +673K 1.0% of company | added 100% | 673K | n/a | Aug 10, 26 |
5am Ventures Vi, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +7.33M 11.0% of company | n/a | 7.33M | n/a | Aug 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LTGO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LTGO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LTGO last traded at $22.55, down 5.77% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LTGO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LTGO 45 times in the last 30 days.
LTGO (Latigo Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.50B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LTGO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LTGO discussion
Sign in to ask a question or join the discussion.